MARKET

JAGX

JAGX

Jaguar Health Inc
NASDAQ
0.6090
-0.0265
-4.17%
After Hours: 0.6222 +0.0132 +2.17% 19:20 02/20 EST
OPEN
0.6356
PREV CLOSE
0.6355
HIGH
0.6489
LOW
0.6090
VOLUME
120.47K
TURNOVER
--
52 WEEK HIGH
25.75
52 WEEK LOW
0.5600
MARKET CAP
2.54M
P/E (TTM)
-0.0113
1D
5D
1M
3M
1Y
5Y
1D
Jaguar Health Declares Special Convertible Preferred Stock Dividend
TipRanks · 4d ago
Jaguar Health Announces One-Time Special Stock Dividend
Benzinga · 4d ago
Jaguar Health announces one-time special stock dividend of Series O Convertible Preferred Stock with no dividend value disclosed
Reuters · 4d ago
Weekly Report: what happened at JAGX last week (0209-0213)?
Weekly Report · 6d ago
First Berlin Equity Research Sets Jaguar Health Price Target at $7.50 with Buy Rating
Reuters · 02/12 14:47
Weekly Report: what happened at JAGX last week (0202-0206)?
Weekly Report · 02/09 10:14
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 02/05 21:05
Weekly Report: what happened at JAGX last week (0126-0130)?
Weekly Report · 02/02 10:14
More
About JAGX
Jaguar Health, Inc. is a commercial stage pharmaceuticals company. The Company is developing prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Its marketed drug Mytesi, (crofelemer 125 mg delayed-release tablets), is a first-in-class oral botanical drug product approved by the FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Its Canalevia-CA1, crofelemer delayed-release tablets drug, is an oral plant-based prescription product that is FDA conditionally approved to treat chemotherapy-induced diarrhea in dogs. It has an exclusive distribution agreement for the sale of Gelclair. It is developing a pipeline of prescription drug product candidates to address unmet needs in gastrointestinal health.

Webull offers Jaguar Health Inc stock information, including NASDAQ: JAGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JAGX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JAGX stock methods without spending real money on the virtual paper trading platform.